ArticleCancer medicine2024

A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.

Anna Furlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.